研究注册表明 COVID-19 对乳腺癌患者的死亡率和住院率的影响。
Registry Study Describes COVID-19 Mortality and Hospitalization in Patients with Breast Cancer.
出版信息
Oncologist. 2021 Feb;26 Suppl 2(Suppl 2):S17-S18. doi: 10.1002/onco.13664. Epub 2021 Jan 5.
Abstract
Nearly half (48%) of patients with active breast cancer or a history of breast cancer and COVID‐19 were hospitalized and 9% died within 30 days of COVID‐19 diagnosis, according to new data from the COVID‐19 and Cancer Consortium registry study.
摘要
根据 COVID-19 和癌症联合会登记研究的新数据，近一半（48%）患有活动性乳腺癌或有乳腺癌病史和 COVID-19 的患者住院，9%的患者在 COVID-19 诊断后 30 天内死亡。
相似文献
1
Registry Study Describes COVID-19 Mortality and Hospitalization in Patients with Breast Cancer.研究注册表明 COVID-19 对乳腺癌患者的死亡率和住院率的影响。
Oncologist. 2021 Feb;26 Suppl 2(Suppl 2):S17-S18. doi: 10.1002/onco.13664. Epub 2021 Jan 5.
2
COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry.癌症患者中的 COVID-19：临床特征和结局——LEOSS 登记处的分析。
Ann Hematol. 2021 Feb;100(2):383-393. doi: 10.1007/s00277-020-04328-4. Epub 2020 Nov 7.
3
ASH Registry Offers Insights on COVID-19 in Patients with Hematologic Malignancies.ASH 注册研究提供血液系统恶性肿瘤患者 COVID-19 相关信息。
Oncologist. 2021 Feb;26 Suppl 1(Suppl 1):S17-S18. doi: 10.1002/onco.13657. Epub 2020 Dec 28.
4
Factors associated with hospitalization, invasive mechanical ventilation treatment and death among all confirmed COVID-19 cases in Norway: Prospective cohort study.与挪威所有确诊 COVID-19 病例住院、有创机械通气治疗和死亡相关的因素：前瞻性队列研究。
Scand J Public Health. 2021 Feb;49(1):41-47. doi: 10.1177/1403494820985172. Epub 2021 Jan 18.
5
Prognostic Impact of Hyponatremia and Hypernatremia in COVID-19 Pneumonia. A HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry Analysis.低钠血症和高钠血症对 COVID-19 肺炎的预后影响。HOPE-COVID-19（COVID-19 的健康结局预测评估）登记分析。
Front Endocrinol (Lausanne). 2020 Nov 30;11:599255. doi: 10.3389/fendo.2020.599255. eCollection 2020.
6
Clinical profile and predictors of in-hospital mortality among older patients hospitalised for COVID-19.老年 COVID-19 住院患者院内死亡的临床特征和预测因素。
Age Ageing. 2021 Feb 26;50(2):326-334. doi: 10.1093/ageing/afaa258.
7
Pregnant women with SARS-CoV-2 infection are at higher risk of death and pneumonia: propensity score matched analysis of a nationwide prospective cohort (COV19Mx).感染新型冠状病毒2（SARS-CoV-2）的孕妇死亡和患肺炎风险更高：一项全国性前瞻性队列（COV19Mx）的倾向评分匹配分析
Ultrasound Obstet Gynecol. 2021 Feb;57(2):224-231. doi: 10.1002/uog.23575.
8
Multiple Biomarker Approach to Risk Stratification in COVID-19.COVID-19风险分层的多种生物标志物方法
Circulation. 2021 Mar 30;143(13):1338-1340. doi: 10.1161/CIRCULATIONAHA.120.053311. Epub 2021 Feb 15.
9
Association between peripheral lymphocyte count and the mortality risk of COVID-19 inpatients.外周血淋巴细胞计数与 COVID-19 住院患者死亡风险的关系。
BMC Pulm Med. 2021 Feb 11;21(1):55. doi: 10.1186/s12890-021-01422-9.
10
Antecedent Administration of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Antagonists and Survival After Hospitalization for COVID-19 Syndrome.COVID-19 综合征住院后血管紧张素转换酶抑制剂或血管紧张素 II 受体拮抗剂的预先给药与生存。
J Am Heart Assoc. 2020 Nov 17;9(22):e017364. doi: 10.1161/JAHA.120.017364. Epub 2020 Oct 7.
引用本文的文献
1
Lung-Heart Outcomes and Mortality through the 2020 COVID-19 Pandemic in a Prospective Cohort of Breast Cancer Radiotherapy Patients.2020年新冠疫情期间乳腺癌放疗患者前瞻性队列研究中的肺心结局与死亡率
Cancers (Basel). 2022 Dec 18;14(24):6241. doi: 10.3390/cancers14246241.
2
Impacts of COVID-19 in Breast Cancer: From Molecular Mechanism to the Treatment Approach.COVID-19 对乳腺癌的影响：从分子机制到治疗方法。
Curr Pharm Biotechnol. 2023;24(2):238-252. doi: 10.2174/1389201023666220421133311.
3
Factors Associated With Hospitalization Among Breast Cancer Patients With COVID-19: A Diverse Multi-Center Los Angeles Cohort Study.与 COVID-19 合并乳腺癌患者住院相关的因素：一个多元化的洛杉矶多中心队列研究。
Clin Breast Cancer. 2022 Jun;22(4):e558-e566. doi: 10.1016/j.clbc.2021.12.005. Epub 2021 Dec 17.
Zotero 插件